Reckitt Sells Skin-Care Brand E45 To Karo In £200m Deal
Karo Pharma is poised to expand its portfolio in the UK with the acquisition of leading skin-care brand E45 from Reckitt.
You may also be interested in...
In the first-half of 2022, Sweden's Karo Pharma saw its sales rise by more than a third thanks to a combination of organic growth and acquisitions. Italy's Recordati reported OTC sales up by almost a fifth as the European market continued to recover post-COVID.
Reckitt’s VMS product sales exceeded expected 4% to 5% Q1 growth due to strong sales in China. Company also increased 2022 guidance due to a strong start.
Reckitt will divest heat rash treatment Dermicool to India's Emami as it continues to reshape its portfolio around brands with higher growth potential.